Cargando…

Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy

BACKGROUND: Inflammatory response and nutritional status are associated with cancer development and progression. The purpose of this study was to explore whether the preoperative fibrinogen-albumin ratio index (FARI) is related to prognosis and chemoradiotherapy outcome of radical surgery after neoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Siyi, Liu, Zhenzhen, Zhou, Xin, Wang, Bingyan, Li, Fei, Ma, Yanpeng, Wang, Wendong, Ma, Junren, Wang, Yuxia, Wang, Hao, Fu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505706/
https://www.ncbi.nlm.nih.gov/pubmed/32982448
http://dx.doi.org/10.2147/CMAR.S273065
_version_ 1783584870242451456
author Lu, Siyi
Liu, Zhenzhen
Zhou, Xin
Wang, Bingyan
Li, Fei
Ma, Yanpeng
Wang, Wendong
Ma, Junren
Wang, Yuxia
Wang, Hao
Fu, Wei
author_facet Lu, Siyi
Liu, Zhenzhen
Zhou, Xin
Wang, Bingyan
Li, Fei
Ma, Yanpeng
Wang, Wendong
Ma, Junren
Wang, Yuxia
Wang, Hao
Fu, Wei
author_sort Lu, Siyi
collection PubMed
description BACKGROUND: Inflammatory response and nutritional status are associated with cancer development and progression. The purpose of this study was to explore whether the preoperative fibrinogen-albumin ratio index (FARI) is related to prognosis and chemoradiotherapy outcome of radical surgery after neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced rectal cancer (LARC). METHODS: In total, 123 patients with LARC who underwent radical surgery after NCRT between June 2012 and December 2018 were collected in this study. Time-dependent receiver operating characteristic (ROC) curve analysis was made to evaluate the ability of the markers for forecasting prognosis. The correlation between FARI and clinicopathological parameters was analyzed. The Kaplan–Meier survival analysis, univariate and multivariate analysis based on Cox proportional hazards models, and subgroup analysis were performed to evaluate overall survival (OS) and disease-free survival (DFS). A nomogram was constructed to evaluate the predictive role of FARI in DFS. RESULTS: The ROC curve analysis showed that the ability of FARI on DFS prediction was superior to those of other inflammatory markers and carcinoembryonic antigen (CEA) (P<0.05). Based on the Youden’s index, the optimal cut-off value of FARI was 8.8%. High FARI patients (>8.8%) showed a poor response to NCRT and a decreased DFS rate (P<0.05). In addition, multivariate analysis revealed that FARI (HR=3.098, P=0.033), neutrophil-to-lymphocyte ratio (NLR), and postoperative T stage were independent prognostic factors for DFS in TNM stage III LARC patients. However, FARI failed to distinguish patients with poor OS. Harrell’s concordance index (C-index) of the nomogram containing FARI (0.807) was obviously higher than that without it (0.732) among LARC patients who underwent radical surgery after NCRT. Moreover, multivariate analysis revealed FARI (OR=3.044, P=0.012) as an independent predictor for response to NCRT. CONCLUSION: Among LARC patients who underwent radical surgery after NCRT, preoperative FARI is an independent prognostic factor for DFS and an independent predictor for response to NCRT.
format Online
Article
Text
id pubmed-7505706
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75057062020-09-24 Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy Lu, Siyi Liu, Zhenzhen Zhou, Xin Wang, Bingyan Li, Fei Ma, Yanpeng Wang, Wendong Ma, Junren Wang, Yuxia Wang, Hao Fu, Wei Cancer Manag Res Original Research BACKGROUND: Inflammatory response and nutritional status are associated with cancer development and progression. The purpose of this study was to explore whether the preoperative fibrinogen-albumin ratio index (FARI) is related to prognosis and chemoradiotherapy outcome of radical surgery after neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced rectal cancer (LARC). METHODS: In total, 123 patients with LARC who underwent radical surgery after NCRT between June 2012 and December 2018 were collected in this study. Time-dependent receiver operating characteristic (ROC) curve analysis was made to evaluate the ability of the markers for forecasting prognosis. The correlation between FARI and clinicopathological parameters was analyzed. The Kaplan–Meier survival analysis, univariate and multivariate analysis based on Cox proportional hazards models, and subgroup analysis were performed to evaluate overall survival (OS) and disease-free survival (DFS). A nomogram was constructed to evaluate the predictive role of FARI in DFS. RESULTS: The ROC curve analysis showed that the ability of FARI on DFS prediction was superior to those of other inflammatory markers and carcinoembryonic antigen (CEA) (P<0.05). Based on the Youden’s index, the optimal cut-off value of FARI was 8.8%. High FARI patients (>8.8%) showed a poor response to NCRT and a decreased DFS rate (P<0.05). In addition, multivariate analysis revealed that FARI (HR=3.098, P=0.033), neutrophil-to-lymphocyte ratio (NLR), and postoperative T stage were independent prognostic factors for DFS in TNM stage III LARC patients. However, FARI failed to distinguish patients with poor OS. Harrell’s concordance index (C-index) of the nomogram containing FARI (0.807) was obviously higher than that without it (0.732) among LARC patients who underwent radical surgery after NCRT. Moreover, multivariate analysis revealed FARI (OR=3.044, P=0.012) as an independent predictor for response to NCRT. CONCLUSION: Among LARC patients who underwent radical surgery after NCRT, preoperative FARI is an independent prognostic factor for DFS and an independent predictor for response to NCRT. Dove 2020-09-17 /pmc/articles/PMC7505706/ /pubmed/32982448 http://dx.doi.org/10.2147/CMAR.S273065 Text en © 2020 Lu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lu, Siyi
Liu, Zhenzhen
Zhou, Xin
Wang, Bingyan
Li, Fei
Ma, Yanpeng
Wang, Wendong
Ma, Junren
Wang, Yuxia
Wang, Hao
Fu, Wei
Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy
title Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy
title_full Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy
title_fullStr Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy
title_full_unstemmed Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy
title_short Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy
title_sort preoperative fibrinogen-albumin ratio index (fari) is a reliable prognosis and chemoradiotherapy sensitivity predictor in locally advanced rectal cancer patients undergoing radical surgery following neoadjuvant chemoradiotherapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505706/
https://www.ncbi.nlm.nih.gov/pubmed/32982448
http://dx.doi.org/10.2147/CMAR.S273065
work_keys_str_mv AT lusiyi preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT liuzhenzhen preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT zhouxin preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT wangbingyan preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT lifei preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT mayanpeng preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT wangwendong preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT majunren preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT wangyuxia preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT wanghao preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy
AT fuwei preoperativefibrinogenalbuminratioindexfariisareliableprognosisandchemoradiotherapysensitivitypredictorinlocallyadvancedrectalcancerpatientsundergoingradicalsurgeryfollowingneoadjuvantchemoradiotherapy